After GSK replaced a popular asthma inhaler with an identical product at a higher price, families reported substantial ...

The global pulmonary drug delivery technology market is projected to grow at a CAGR of approximately 5% over the next five ...

Glaxo Smith Kline’s decision to discontinue a popular children’s asthma inhaler, Flovent, more than two years ago has caused ...

A Somerset woman says she suffered a severe asthma attack after having her prescription changed without consultation. Sue* ...

Kenox Pharmaceuticals Inc. (Kenox), a fast‑growing contract development and manufacturing organization (CDMO) dedicated exclusively to Orally Inhaled and Nasal Drug Products (OINDPs) and Ophthalmic ...

A new U.S. study found Anoro Elipta to be better than Bevespi Aerosphere or Stiolto Respimat at lowering the risk of disease ...

"Today's approval of the first generic fluticasone propionate inhalation aerosol represents an important step in expanding access to affordable asthma treatment," said Iilun Murph ...

Key market opportunities in the inhaler solution market include the rising demand driven by increased respiratory disorders ...

Key opportunities in the drug delivery devices market include expanding digital health partnerships for innovative injectable ...

Are you suffering from severe asthma? Avoid playing with dry colours this Holi, instead, read on to know the other ...

Add Yahoo as a preferred source to see more of our stories on Google. Children who use a lot of blue reliever inhalers are several times more likely to have severe asthma attacks [BBC] A new study is ...